CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Importance of trough levels and antibody titers on the efficacy and safety of Infliximab therapy in inflammatory bowel disease
DOI 10.1055/s-0032-1312407
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Molnár, K Farkas, É Pallagi, R Gyulai, R Kui, Z Szepes, M Szűcs, F Nagy, T Wittmann
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Infliximab is effective for the treatment of refractory inflammatory bowel disease (IBD). Nevertheless, up to 40% of patients lose response to infliximab and 10% develops severe side effects or allergic reaction. The aim of this study was to assess the clinical value of measuring infliximab trough levels (TL) and antibodies to infliximab (ATI) concentrations in IBD patients who lost response or develop…
Zitieren
Zitierempfehlung
T Molnár, K Farkas, É Pallagi, R Gyulai, R Kui, Z Szepes, M Szűcs, F Nagy, T Wittmann (2012) Importance of trough levels and antibody titers on the efficacy and safety of Infliximab therapy in inflammatory bowel disease. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0032-1312407
Mit CareLit weiterarbeiten